Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services. By submitting this information, I agree to the privacy policy and to learn more about ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...

Policymakers must implement changes now to enhance data for EU’s consolidated tape, urges EFAMA The European Fund and Asset Management Association (EFAMA) advocates for policy improvements and changes ...

WICHITA, Kan. (KSNW) – Debate continues over the future of data centers in Sedgwick County. One Kansas lawmaker is calling for a three-year moratorium, while county commissioners have set a shorter ...

Feb. 18 (UPI) --Human Rights Watch urged Venezuela's government led by Delcy Rodriguez to dismantle what it described as the country's repressive state apparatus and implement deep judicial and ...

South Korea has fined luxury fashion brands Louis Vuitton, Christian Dior Couture, and Tiffany $25 million for failing to implement adequate security measures, which facilitated unauthorized access ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Ethical data practices can help to ensure innovation delivers value without compromising ...

Starting next year, Apple will allow app sideloading and external payment links for users in Brazil, following an antitrust settlement with local regulators. Here are the details. In 2022, Latin ...

NAIROBI, Dec 11 (Reuters) - A Kenyan court has suspended part of a health funding agreement the government signed with the United States on December 4, worth more than $1.6 billion, until it hears a ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...